Ditchcarbon
  • Contact
  1. Organizations
  2. Janssen Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
CA
updated 8 months ago

Janssen Inc. Sustainability Profile

Company website

Janssen Inc., a subsidiary of Johnson & Johnson, is a leading pharmaceutical company headquartered in California. Established in 1953, Janssen has made significant strides in the healthcare industry, focusing on innovative solutions across various therapeutic areas, including oncology, immunology, and neuroscience. With a strong presence in North America and Europe, Janssen is renowned for its commitment to research and development, delivering groundbreaking medications that address unmet medical needs. Core products such as Stelara and Imbruvica exemplify the company's dedication to advancing patient care through unique mechanisms of action and robust clinical evidence. Janssen's market position is bolstered by its continuous investment in cutting-edge science and strategic partnerships, solidifying its reputation as a trusted leader in the pharmaceutical sector.

DitchCarbon Score

How does Janssen Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

78

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Janssen Inc.'s score of 78 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.

88%

Let us know if this data was useful to you

Janssen Inc.'s reported carbon emissions

Inherited from Johnson & Johnson

Janssen Inc., headquartered in California, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Johnson & Johnson, and any climate commitments or emissions data would be inherited from its parent organisation. Janssen Inc. aligns with Johnson & Johnson's sustainability initiatives, which include various climate commitments and reduction targets. However, specific reduction targets or achievements for Janssen Inc. are not detailed in the available information. The company participates in industry-standard initiatives such as the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and RE100, all of which are cascaded from Johnson & Johnson. As part of its corporate family, Janssen Inc. is expected to adhere to the overarching climate strategies set by Johnson & Johnson, which focus on reducing greenhouse gas emissions across all scopes. However, without specific data or targets for Janssen Inc. itself, the details remain vague.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

19902006200720082009201020112012201320142015201620172018201920202021202220232024
Scope 1
308,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
751,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
-
-
00,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is Janssen Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Janssen Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Janssen Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Janssen Inc. is in CA, which has a very low grid carbon intensity relative to other regions.

Janssen Inc.'s Scope 3 Categories Breakdown

Janssen Inc.'s Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
72%
Upstream Transportation & Distribution
9%
Business Travel
7%
Capital Goods
3%
Employee Commuting
3%
Fuel and Energy Related Activities
2%
Use of Sold Products
2%
End-of-Life Treatment of Sold Products
<1%
Upstream Leased Assets
<1%

Janssen Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Janssen Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Janssen Inc.'s Emissions with Industry Peers

GlaxoSmithKline Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Pharmascience Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Johnson & Johnson Inc.

CA
•
Health and social work services (85)
Updated 2 months ago

Bristol Myers Squibb Canada Co.

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Astrazeneca Canada Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Merck Canada Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy